BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 16957968)

  • 1. Utilizing quantitative polymerase chain reaction to evaluate prostate stem cell antigen as a tumor marker in pancreatic cancer.
    Grubbs EG; Abdel-Wahab Z; Tyler DS; Pruitt SK
    Ann Surg Oncol; 2006 Dec; 13(12):1645-54. PubMed ID: 16957968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External beam radiotherapy (EBRT) suppressed prostate stem cell antigen (PSCA) mRNA expression in clinically localized prostate cancer.
    Zhigang Z; Wenlu S
    Prostate; 2007 May; 67(6):653-60. PubMed ID: 17342746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of prostate stem cell antigen in human clear cell renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis.
    Elsamman EM; Fukumori T; Tanimoto S; Nakanishi R; Takahashi M; Toida K; Kanayama HO
    BJU Int; 2006 Sep; 98(3):668-73. PubMed ID: 16925770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate stem cell antigen is overexpressed in prostate cancer metastases.
    Lam JS; Yamashiro J; Shintaku IP; Vessella RL; Jenkins RB; Horvath S; Said JW; Reiter RE
    Clin Cancer Res; 2005 Apr; 11(7):2591-6. PubMed ID: 15814638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse transcriptase-polymerase chain reaction and immunohistochemical studies for detection of prostate stem cell antigen expression in prostate cancer: potential value in molecular staging of prostate cancer.
    Joung JY; Yang SO; Jeong IG; Han KS; Seo HK; Chung J; Park WS; Lee KH
    Int J Urol; 2007 Jul; 14(7):635-43. PubMed ID: 17645609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of circulating tumor cells by cytokeratin 20 and prostate stem cell antigen RT-PCR in blood of patients with gastrointestinal cancers.
    Lukyanchuk VV; Friess H; Kleeff J; Osinsky SP; Ayuni E; Candinas D; Roggo A
    Anticancer Res; 2003; 23(3B):2711-6. PubMed ID: 12894563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice.
    Ohuchida K; Mizumoto K; Fujita H; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    J Pathol; 2006 Sep; 210(1):42-8. PubMed ID: 16794990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.
    Ohuchida K; Mizumoto K; Miyasaka Y; Yu J; Cui L; Yamaguchi H; Toma H; Takahata S; Sato N; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    J Pathol; 2007 Nov; 213(3):275-82. PubMed ID: 17940995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer.
    Ohuchida K; Mizumoto K; Ogura Y; Ishikawa N; Nagai E; Yamaguchi K; Tanaka M
    Clin Cancer Res; 2005 Mar; 11(6):2285-92. PubMed ID: 15788678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
    Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C
    Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of prostate stem cell antigen and Claudin-4 in human pancreatic carcinoma].
    Yagn WB; Cai F; Cheng CT; Cao G; Qin ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Dec; 30(6):728-31. PubMed ID: 19180924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma.
    Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Sakai H; Fujita H; Nakata K; Tanaka M
    Ann Surg Oncol; 2010 Dec; 17(12):3120-8. PubMed ID: 20652642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.
    Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J
    Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis.
    Guweidhi A; Kleeff J; Giese N; El Fitori J; Ketterer K; Giese T; Büchler MW; Korc M; Friess H
    Carcinogenesis; 2004 Sep; 25(9):1575-85. PubMed ID: 15073049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of the carboxyl ester lipase gene in pancreas and pancreatic adenocarcinomas.
    Reuss R; Aberle S; Klingel K; Sauter M; Greschniok A; Franke FE; Padberg W; Blin N
    Int J Oncol; 2006 Sep; 29(3):649-54. PubMed ID: 16865281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity.
    Erkan M; Kleeff J; Gorbachevski A; Reiser C; Mitkus T; Esposito I; Giese T; Büchler MW; Giese NA; Friess H
    Gastroenterology; 2007 Apr; 132(4):1447-64. PubMed ID: 17408641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.
    Masui T; Doi R; Koshiba T; Fujimoto K; Tsuji S; Nakajima S; Koizumi M; Toyoda E; Tulachan S; Ito D; Kami K; Mori T; Wada M; Noda M; Imamura M
    Clin Cancer Res; 2003 May; 9(5):1779-84. PubMed ID: 12738734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D.
    Whiteman HJ; Weeks ME; Dowen SE; Barry S; Timms JF; Lemoine NR; Crnogorac-Jurcevic T
    Cancer Res; 2007 Sep; 67(18):8633-42. PubMed ID: 17875703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
    Zhao L; Cui Q; Lu Z; Chen J
    Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.